PortfoliosLab logoPortfoliosLab logo
UNH vs. LLY
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

UNH vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UnitedHealth Group Incorporated (UNH) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

UNH vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UNH
UnitedHealth Group Incorporated
-17.39%-33.14%-2.41%0.80%6.94%45.20%21.25%20.00%14.52%39.83%
LLY
Eli Lilly and Company
-14.27%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Fundamentals

Market Cap

UNH:

$246.24B

LLY:

$825.96B

EPS

UNH:

$15.62

LLY:

$22.96

PE Ratio

UNH:

17.32

LLY:

40.06

PS Ratio

UNH:

0.55

LLY:

12.68

PB Ratio

UNH:

2.46

LLY:

31.13

Total Revenue (TTM)

UNH:

$447.57B

LLY:

$65.18B

Gross Profit (TTM)

UNH:

$82.92B

LLY:

$54.62B

EBITDA (TTM)

UNH:

$23.19B

LLY:

$27.94B

Returns By Period

In the year-to-date period, UNH achieves a -17.39% return, which is significantly lower than LLY's -14.27% return. Over the past 10 years, UNH has underperformed LLY with an annualized return of 9.39%, while LLY has yielded a comparatively higher 30.92% annualized return.


UNH

1D
3.36%
1M
-7.02%
YTD
-17.39%
6M
-20.50%
1Y
-46.88%
3Y*
-15.31%
5Y*
-4.29%
10Y*
9.39%

LLY

1D
3.74%
1M
-12.57%
YTD
-14.27%
6M
20.93%
1Y
12.19%
3Y*
39.90%
5Y*
39.16%
10Y*
30.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UNH vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UNH
UNH Risk / Return Rank: 1212
Overall Rank
UNH Sharpe Ratio Rank: 66
Sharpe Ratio Rank
UNH Sortino Ratio Rank: 1010
Sortino Ratio Rank
UNH Omega Ratio Rank: 66
Omega Ratio Rank
UNH Calmar Ratio Rank: 1515
Calmar Ratio Rank
UNH Martin Ratio Rank: 2525
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 5151
Overall Rank
LLY Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 4848
Sortino Ratio Rank
LLY Omega Ratio Rank: 4949
Omega Ratio Rank
LLY Calmar Ratio Rank: 5353
Calmar Ratio Rank
LLY Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UNH vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UnitedHealth Group Incorporated (UNH) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UNHLLYDifference

Sharpe ratio

Return per unit of total volatility

-0.92

0.29

-1.21

Sortino ratio

Return per unit of downside risk

-1.15

0.69

-1.84

Omega ratio

Gain probability vs. loss probability

0.81

1.10

-0.28

Calmar ratio

Return relative to maximum drawdown

-0.77

0.42

-1.19

Martin ratio

Return relative to average drawdown

-1.02

1.02

-2.04

UNH vs. LLY - Sharpe Ratio Comparison

The current UNH Sharpe Ratio is -0.92, which is lower than the LLY Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of UNH and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


UNHLLYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.92

0.29

-1.21

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.14

1.23

-1.36

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.32

1.04

-0.73

Sharpe Ratio (All Time)

Calculated using the full available price history

0.60

0.56

+0.04

Correlation

The correlation between UNH and LLY is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

UNH vs. LLY - Dividend Comparison

UNH's dividend yield for the trailing twelve months is around 3.27%, more than LLY's 0.68% yield.


TTM20252024202320222021202020192018201720162015
UNH
UnitedHealth Group Incorporated
3.27%2.64%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%
LLY
Eli Lilly and Company
0.68%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Drawdowns

UNH vs. LLY - Drawdown Comparison

The maximum UNH drawdown since its inception was -74.37%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for UNH and LLY.


Loading graphics...

Drawdown Indicators


UNHLLYDifference

Max Drawdown

Largest peak-to-trough decline

-74.37%

-68.24%

-6.13%

Max Drawdown (1Y)

Largest decline over 1 year

-60.06%

-30.26%

-29.80%

Max Drawdown (5Y)

Largest decline over 5 years

-61.39%

-34.48%

-26.91%

Max Drawdown (10Y)

Largest decline over 10 years

-61.39%

-34.48%

-26.91%

Current Drawdown

Current decline from peak

-55.14%

-17.00%

-38.14%

Average Drawdown

Average peak-to-trough decline

-14.63%

-19.25%

+4.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

45.40%

12.39%

+33.01%

Volatility

UNH vs. LLY - Volatility Comparison

The current volatility for UnitedHealth Group Incorporated (UNH) is 7.72%, while Eli Lilly and Company (LLY) has a volatility of 9.04%. This indicates that UNH experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


UNHLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.72%

9.04%

-1.32%

Volatility (6M)

Calculated over the trailing 6-month period

29.34%

26.21%

+3.13%

Volatility (1Y)

Calculated over the trailing 1-year period

51.10%

42.44%

+8.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.26%

32.14%

-0.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.84%

29.80%

+0.04%

Financials

UNH vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between UnitedHealth Group Incorporated and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B120.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
113.22B
19.29B
(UNH) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

UNH vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between UnitedHealth Group Incorporated and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
16.3%
85.1%
Portfolio components
UNH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, UnitedHealth Group Incorporated reported a gross profit of 18.49B and revenue of 113.22B. Therefore, the gross margin over that period was 16.3%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a gross profit of 16.41B and revenue of 19.29B. Therefore, the gross margin over that period was 85.1%.

UNH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, UnitedHealth Group Incorporated reported an operating income of 380.00M and revenue of 113.22B, resulting in an operating margin of 0.3%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported an operating income of 8.78B and revenue of 19.29B, resulting in an operating margin of 45.5%.

UNH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, UnitedHealth Group Incorporated reported a net income of 2.18B and revenue of 113.22B, resulting in a net margin of 1.9%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a net income of 6.64B and revenue of 19.29B, resulting in a net margin of 34.4%.